The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made… Read More
News round-up for 4 – 8 May by Bruno Quinney, Content Team at DDW. This week, the FDA has advanced an initiative to implement real-time clinical trials. Elsewhere, UCB has made headlines for through an acquisition and its cancer research venture. The top stories: FDA moves… Read More
A previously undiscovered target for treating malaria could pave the way for a new generation of drugs, experts say. Researchers from the Universities of Bath and Leeds, UK have made a significant advance in the fight against malaria by uncovering a promising new potential target for drug discovery. … Read More
A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. The research was led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the… Read More
Phase II trial results for Levicept’s LEVI-04, a novel and first in class neurotrophin-3 (NT-3) inhibitor, have shown that the drug was highly effective and well tolerated. The study enrolled more than 510 participants with pain and disability due to osteoarthritis of the knee. It was… Read More
